We are live on ! Find out more
BFS

Bradley Foster & Sargent Portfolio holdings

AUM $6.44B
1-Year Est. Return 25.27%
This Fund
S&P 500
This Quarter Est. Return
+11.01%
1 Year Est. Return
+25.27%
3 Year Est. Return
+77.25%
5 Year Est. Return
+101.72%
10 Year Est. Return
AUM
$4.82B
AUM Growth
+$567M
Cap. Flow
+$147M
Cap. Flow %
3.05%
Top 10 Hldgs %
30.79%
Holding
467
New
60
Increased
188
Reduced
129
Closed
20

Top Buys

Rank Stock Value
1
NFLX icon
Netflix
NFLX
+$32.4M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$27.6M
3
RTX icon
RTX Corp
RTX
+$10.8M
4
AAPL icon
Apple
AAPL
+$10.6M
5
IQV icon
IQVIA
IQV
+$8.91M

Top Sells

Rank Stock Value
1
CMCSA icon
Comcast
CMCSA
+$27.9M
2
FISV
Fiserv Inc
FISV
+$13M
3
B
Barrick Mining
B
+$8.89M
4
TECH icon
Bio-Techne
TECH
+$4.84M
5
BDX icon
Becton Dickinson
BDX
+$3.41M

Sector Composition

Rank Sector Weight
1 Technology 20.81%
2 Healthcare 17.28%
3 Financials 10.81%
4 Consumer Discretionary 9.57%
5 Industrials 9.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRAX icon
426
Praxis Precision Medicines
PRAX
$10.2B
$217K ﹤0.01%
733
ONL
427
Orion Office REIT
ONL
$156M
$216K ﹤0.01%
+11,585
New +$229K
PLD icon
428
Prologis
PLD
$132B
$216K ﹤0.01%
+1,283
New +$191K
HUBB icon
429
Hubbell
HUBB
$26.7B
$213K ﹤0.01%
+1,023
New +$205K
ALLE icon
430
Allegion
ALLE
$14.1B
$212K ﹤0.01%
1,601
CDK
431
DELISTED
CDK Global, Inc.
CDK
$211K ﹤0.01%
5,059
-170
-3% -$7.13K
CTRA
432
DELISTED
Coterra Energy
CTRA
$209K ﹤0.01%
10,977
WASH icon
433
Washington Trust Bancorp
WASH
$735M
$209K ﹤0.01%
+3,700
New +$206K
CRSP icon
434
CRISPR Therapeutics
CRSP
$5.17B
$208K ﹤0.01%
2,751
+160
+6% +$14K
CLH icon
435
Clean Harbors
CLH
$16.4B
$207K ﹤0.01%
2,078
CLVT icon
436
Clarivate
CLVT
$1.21B
$205K ﹤0.01%
+8,725
New +$202K
CHRW icon
437
C.H. Robinson
CHRW
$17.3B
$204K ﹤0.01%
+1,900
New +$185K
A icon
438
Agilent Technologies
A
$42B
$203K ﹤0.01%
1,272
VXRT
439
DELISTED
Vaxart
VXRT
$125K ﹤0.01%
20,000
BKT icon
440
BlackRock Income Trust
BKT
$342M
$80K ﹤0.01%
+4,722
New +$84.1K
HIMS icon
441
Hims & Hers Health
HIMS
$7.35B
$65K ﹤0.01%
+10,000
New +$72.3K
CTSO icon
442
Cytosorbents Corp
CTSO
$22.7M
$43K ﹤0.01%
10,250
-23,990
-70% -$135K
PBEE
443
DELISTED
Invesco PureBeta FTSE Emerging Markets ETF
PBEE
$34K ﹤0.01%
+19,500
New +$550K
ADPT icon
444
Adaptive Biotechnologies
ADPT
$4.05B
-62,126
Closed -$2.11M
ALLY icon
445
Ally Financial
ALLY
$13.3B
-4,000
Closed -$204K
ALNY icon
446
Alnylam Pharmaceuticals
ALNY
$29B
-5,223
Closed -$986K
ARKK icon
447
ARK Innovation ETF
ARKK
$6.37B
-1,938
Closed -$214K
ARKW icon
448
ARK Web x.0 ETF
ARKW
$1.77B
-1,565
Closed -$217K
BABA icon
449
Alibaba
BABA
$317B
-1,606
Closed -$238K
CMRC
450
Commerce.com Inc Series 1
CMRC
$175M
-33,487
Closed -$1.7M

Similar funds

Bradley Foster & Sargent's Q4 2021 Portfolio in Review

As of Q4 2021, Bradley Foster & Sargent held 467 positions worth $4.82B, up 13% from $4.26B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Bradley Foster & Sargent deployed $147M of net new capital in Q4 2021, opening 60 new positions and adding to 188 existing holdings. Its largest new stake was iShares Russell Mid-Cap ETF: 81,268 shares worth $6.75M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Comcast, an estimated $27.9M trimmed.

  • Bradley Foster & Sargent's largest Q4 2021 buy was iShares Russell Mid-Cap ETF: 81,268 shares worth $6.75M.
  • Bradley Foster & Sargent added most to Netflix in Q4 2021, an estimated $32.4M increase.
  • Bradley Foster & Sargent's biggest Q4 2021 reduction was Comcast, cutting an estimated $27.9M.
  • Bradley Foster & Sargent fully exited Adaptive Biotechnologies in Q4 2021, selling an estimated $2.11M.
  • Bradley Foster & Sargent's ten largest holdings make up 31% of its $4.82B portfolio in Q4 2021.
  • Bradley Foster & Sargent opened 60 new positions and closed 20 in Q4 2021.
  • Bradley Foster & Sargent's portfolio value rose 13% quarter-over-quarter to $4.82B.

Based on Bradley Foster & Sargent's 13F filing for Q4 2021, filed 11 Mar 2022.